Karnataka cancels 16 drug licences in ₹5-crore counterfeit medicines crackdown
Karnataka FDA has cancelled 16 drug licences and suspended eight after raids tied to a Bidadi farmhouse seized suspected counterfeit injections and expired medicines worth over ₹4.25 crore. Investigators are examining alleged supply links to more than 90 hospitals and clinics.
What happened
Karnataka FDA cancelled 16 licences and suspended eight amid a counterfeit-drug probe. Raids linked to a Bidadi farmhouse seized injections and expired
Key facts
- 16 drug licences cancelled
- 8 drug licences suspended
- 5,640 CEFIAVIGENT injection vials seized
- CEFIAVIGENT seizure valued at ₹3.38 crore
- 1,531 HIZLAM injections seized
What changed
Karnataka FDA cancelled 16 licences and suspended eight amid a counterfeit-drug probe. Raids linked to a Bidadi farmhouse seized injections and expired medicines worth over ₹4.25 crore, while investigators examine alleged supply links to more than 90 hospitals and clinics.
Why this matters
Pharma distributors and healthcare providers should tighten supplier verification, batch traceability and inventory audits as Karnataka’s licence cancellations expose potential counterfeit-drug links across more than 90 care sites.
What to watch
- Names of the 16 cancelled and eight suspended licence holders, plus whether they supplied organized hospital or pharmacy-chain accounts.
- Laboratory confirmation of counterfeit, substandard or expired products and identification of affected brands, molecules and batch numbers.
- Expansion of raids or enforcement into Bengaluru, Ramanagara, neighboring states or online/B2B pharmaceutical channels.
- Hospital notifications, patient-safety alerts, product recalls or adverse-event reports tied to the seized injections.
- Evidence that the alleged network supplied a material share of the more than 90 hospitals and clinics under review.